Literature DB >> 7365579

The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses.

R C Welliver, T N Kaul, T I Putnam, M Sun, K Riddlesberger, P L Ogra.   

Abstract

Serum antibody responses to primary and secondary infections with respiratory syncytial virus were determined in 67 hospitalized infants. Responses in IgG, IgM, and IgA immunoglobulin fractions were assayed using an indirect immunofluorescent technique. Infection was confirmed by identification of RSV antigen in nasopharyngeal secretions using indirect immunofluorescence, and by recovery of the virus in tissue culture. IgM specific antibody response was commonly observed within a few days of onset of primary infection and persisted from two to ten weeks. Increases in titer of virus-specific IgG and IgA were observed in infants aged 6 months or more at the time of infection than in younger infants. At one year after primary infection, IgA and IgM specific antibody was undetectable, and IgG antibody was absent or present in low titer. Subsequent reinfection result ed in accelerated antibody response in all three classes of serum immunoglobulin. High titers of RSV-specific IgG, IgM, and IgA antibody were detectable at five and seven days after reinfection. These observations may explain the relatively mild nature of clinical illness associated with RSV reinfections in childhood.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7365579     DOI: 10.1016/s0022-3476(80)80547-6

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  45 in total

Review 1.  The respiratory syncitial virus and its role in acute bronchiolitis.

Authors:  M L Everard; A D Milner
Journal:  Eur J Pediatr       Date:  1992-09       Impact factor: 3.183

Review 2.  Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections.

Authors:  D Nadal; P L Ogra
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Antibody response to respiratory syncytial virus infection in children <18 months old.

Authors:  Susanna Esposito; Elisa Scarselli; Mara Lelii; Alessia Scala; Alessandra Vitelli; Stefania Capone; Marco Fornili; Elia Biganzoli; Annalisa Orenti; Alfredo Nicosia; Riccardo Cortese; Nicola Principi
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 4.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

5. 

Authors:  François Freymuth; Geneviève Eugène; Jacques Brouard; Astrid Vabret; Joëlle Petitjean; Françoise Bonnin
Journal:  Ann Inst Pasteur Actual       Date:  2000-04-05

Review 6.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

7.  Class-specific antibodies to bovine respiratory syncytial virus in experimentally infected lambs.

Authors:  R Sharma; Z Woldehiwet
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

8.  Rapid diagnosis of respiratory syncytial virus infection by antigen immunofluorescence detection with monoclonal antibodies and immunoglobulin M immunofluorescence test.

Authors:  Z Kadi; S Dali; S Bakouri; A Bouguermouh
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

9.  Inability to evoke a long-lasting protective immune response to respiratory syncytial virus infection in mice correlates with ineffective nasal antibody responses.

Authors:  Richard Singleton; Nathalie Etchart; Sam Hou; Lisa Hyland
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

10.  Serodiagnosis of respiratory syncytial virus (RSV) infection in children as measured by detection of RSV-specific immunoglobulins G, M, and A with enzyme-linked immunosorbent assay.

Authors:  M J Meddens; P Herbrink; J Lindeman; W C van Dijk
Journal:  J Clin Microbiol       Date:  1990-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.